[ad_1]
British surgeons have tested a technique to quickly identify cancer cells in the brain, making the operation more efficient.
Yesterday, according to the Guardian newspaper, tests were conducted on people suspected of suffering from the so-called "dermal glomeruloma", the most common form of brain cancer, using a drug compound called "5-ALA", and taken once by the patient until the cells begin to form. Cancer, which allows surgeons to remove damaged cells without compromising intact cells.
Previous research has shown that the 5-ALA compound accumulates in rapidly growing cancer cells, but surgeons apparently could not know its exact location until the technique was tested.
The study was conducted on 99 patients suspected of developing brain tumors treated at the Royal Liverpool Hospital, King University Hospital London and Edinburgh University Hospital in Cambridge, aged 23 to 77 years. During operations, surgeons reported seeing a lightning bolt in 85 patients, 81 of whom were confirmed to be at advanced stages of illness and only one had low grade disease, while others did not. 39; have not been able to evaluate the rest.
"Neurologists should be able to distinguish tumor tissue from other brain tissue, especially when the tumor contains fast-growing cancer cells," said Dr. Colin Watts, professor of brain and neurosurgery at the University from Birmingham.
"The advantage of this technique is that it allows the disease to be detected at an advanced stage more quickly and that more tumors can be removed more safely, with fewer complications."
[ad_2]
Source link
